Speakers

Amy House

Integration & Transition Lead, Former: Senior Director, Chief of Staff to Chief Medical Officer • Gyroscope

Amy House has over 20 year of experience in health care and the life sciences. Most recently, she was Chief of Staff to the Chief Medical Officer at Gyroscope Therapeutics, a clinical-stage gene therapy company acquired by Novartis last year for $800M. She also served as the Gyroscope Integration and Transition Lead following the aquisition. Previously, Amy developed and managed strategic alliances for faculty with industry partners and investors at Johns Hopkins Technology Ventures. She also has extensive management consulting experience with health care organizations and life sciences companies, including work with Sage Growth Partners where she partnered with early and growth-stage companies to assess market opportunities and develop Go-to-Market strategies. Amy has an MBA from Duke University and a BA in Public Health from Johns Hopkins University. 

Also Speaking

Bernd Leistler

Vice President Production • Sartorius CellGenix

Ryan Crisman

Chief Technical Officer • Umoja Biopharma

Ian Goodwin

Director, Global Program Design, • Fujifilm Diosynth Biotechnologies

Also Speaking

Image

2025 Downloadable Agenda

Download the post-event report for Advanced Therapies Week 2024.
Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.